Paper41006729
Long term anticoagulation for Catheter-Related deep vein thrombosis of the upper extremities in women with cancer: retrospective analysis of effectiveness and safety outcomes.
Cavallaro C and 11 others. J Thromb Thrombolysis, 2025. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Long term anticoagulation for Catheter-Related deep vein thrombosis of the upper extremities in women with cancer: retrospective analysis of effectiveness and safety outcomes. Papers, record 41006729. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41006729
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Long term anticoagulation for Catheter-Related deep vein thrombosis of the upper extremities in women with cancer: retrospective analysis of effectiveness and safety outcomes.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anticoagulants | Major topic |
| Upper Extremity Deep Vein Thrombosis | Major topic |
| Neoplasms | Major topic |
| Central Venous Catheters | Major topic |
| Humans | |
| Female | |
| Retrospective Studies | |
| Middle Aged | |
| Aged | |
| Treatment Outcome | |
| Hemorrhage | |
| Adult | |
| Recurrence | |
| Time Factors | |
| Upper Extremity |
Source PubMed
References35
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 12484710 | Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism. | Ann Intern Med | 2002 | https://conductscience.org/library/papers/12484710 | PubMed |
| 2 | 26407753 | Oral apixaban for the treatment of venous thromboembolism in cancer patients: results from the AMPLIFY trial. | J Thromb Haemost | 2015 | https://conductscience.org/library/papers/26407753 | PubMed |
| 3 | 35837602 | A Single Center Retrospective Cohort Study Comparing Different Anticoagulants for the Treatment of Catheter-Related Thrombosis of the Upper Extremities in Women With Gynecologic and Breast Cancer. | Front Cardiovasc Med | 2022 | https://conductscience.org/library/papers/35837602 | PubMed |
| 4 | 23252176 | Reducing upper extremity deep vein thrombosis when inserting PICCs. | Br J Nurs | 2012 | https://conductscience.org/library/papers/23252176 | PubMed |
| 5 | 38065528 | Management of catheter-related upper extremity deep vein thrombosis in patients with cancer: a systematic review and meta-analysis. | J Thromb Haemost | 2024 | https://conductscience.org/library/papers/38065528 | PubMed |
| 6 | 20434007 | Bleeding complications associated with anticoagulant therapy in patients with cancer. | Thromb Res | 2010 | https://conductscience.org/library/papers/20434007 | PubMed |
| 7 | 36774305 | Risk factors for recurrence and major bleeding in patients with cancer-associated venous thromboembolism. | Eur J Intern Med | 2023 | https://conductscience.org/library/papers/36774305 | PubMed |
| 8 | 8775526 | Hickman catheters: left-sided insertion, male gender, and obesity are associated with an increased risk of complications. | Aust N Z J Med | 1996 | https://conductscience.org/library/papers/8775526 | PubMed |
| 9 | 28316279 | Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism. | N Engl J Med | 2017 | https://conductscience.org/library/papers/28316279 | PubMed |
| 10 | 26314776 | Central venous access in oncology: ESMO Clinical Practice Guidelines. | Ann Oncol | 2015 | https://conductscience.org/library/papers/26314776 | PubMed |
| 11 | 37075273 | Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Guideline Update. | J Clin Oncol | 2023 | https://conductscience.org/library/papers/37075273 | PubMed |
| 12 | 35114046 | Low dose apixaban as secondary prophylaxis of venous thromboembolism in cancer patients - 30 months follow-up. | J Thromb Haemost | 2022 | https://conductscience.org/library/papers/35114046 | PubMed |
| 13 | 26992301 | A RIETE registry analysis of recurrent thromboembolism and hemorrhage in patients with catheter-related thrombosis. | J Vasc Surg Venous Lymphat Disord | 2015 | https://conductscience.org/library/papers/26992301 | PubMed |
| 14 | 34816583 | Extended anticoagulation treatment for cancer-associated thrombosis-Rates of recurrence and bleeding beyond 6 months: A systematic review. | J Thromb Haemost | 2022 | https://conductscience.org/library/papers/34816583 | PubMed |
| 15 | 40162636 | Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism. | N Engl J Med | 2025 | https://conductscience.org/library/papers/40162636 | PubMed |
| 16 | 23697825 | Risk of venous thromboembolism associated with peripherally inserted central catheters: a systematic review and meta-analysis. | Lancet | 2013 | https://conductscience.org/library/papers/23697825 | PubMed |
| 17 | 23216615 | Apixaban for extended treatment of venous thromboembolism. | N Engl J Med | 2013 | https://conductscience.org/library/papers/23216615 | PubMed |
| 18 | 21366477 | Clinical practice. Deep-vein thrombosis of the upper extremities. | N Engl J Med | 2011 | https://conductscience.org/library/papers/21366477 | PubMed |
| 19 | 33570602 | American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer. | Blood Adv | 2021 | https://conductscience.org/library/papers/33570602 | PubMed |
| 20 | 25680892 | A systematic review of patient-related risk factors for catheter-related thrombosis. | J Thromb Thrombolysis | 2015 | https://conductscience.org/library/papers/25680892 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42724952 | Inflammation-coagulation biomarkers predict catheter-related thrombosis following peripherally inserted central catheter placement in patients with hematologic malignancies: a retrospective cohort study. | Transl Cancer Res | 2026 | https://conductscience.org/library/papers/42724952 | PubMed |
| 42194892 | Risk Factors for Catheter-Related Thrombosis. | J Clin Med | 2026 | https://conductscience.org/library/papers/42194892 | PubMed |
| 41405755 | Thrombosis in patients with cancer: challenges and advances. | J Thromb Thrombolysis | 2025 | https://conductscience.org/library/papers/41405755 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41006729
GET https://conductscience.org/api/papers/v1/41006729/references?page=2